España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Abbott Laboratories
ABT
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Abbott Laboratories (ABT) Forecast
News
Earnings
Abbott Laboratories (ABT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Abbott Laboratories (NYSE:ABT) Stock
Abbott Laboratories Stock (NYSE: ABT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
Insulet Announces Omnipod 5 System Is Now Com...
Benzinga Newsdesk
Monday, November 18, 2024
Abbott's Amplatzer Amulet Device Demonstrates...
Benzinga Newsdesk
Saturday, November 16, 2024
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Juan Spínelli
Tuesday, November 05, 2024
Analyst Ratings For Abbott Laboratories
Benzinga Insights
Barclays Maintains Overweight on Abbott Labor...
Benzinga Newsdesk
Monday, November 04, 2024
Abbott's Esprit BTK System Shows Sustained Tw...
Benzinga Newsdesk
Friday, November 01, 2024
Abbott Laboratories shares are trading higher...
Benzinga Newsdesk
Reported October 31: Abbott Laboratories And ...
Benzinga Newsdesk
Thursday, October 24, 2024
Abbott Initiates First-Of-Its0Kind Clinical T...
Benzinga Newsdesk
Tuesday, October 22, 2024
P/E Ratio Insights for Abbott Laboratories
Benzinga Insights
Friday, October 18, 2024
Shares of surgical tool and medical instrumen...
Benzinga Newsdesk
Thursday, October 17, 2024
Abbott Labs Path To Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
Vandana Singh
Abbott's Growth and Dividends Make It a Smart Portfolio Pick
MarketBeat
Bernstein Maintains Outperform on Abbott Labo...
Benzinga Newsdesk
UBS Maintains Buy on Abbott Laboratories, Rai...
Benzinga Newsdesk
Jefferies Maintains Hold on Abbott Laboratori...
Benzinga Newsdesk
Mizuho Maintains Neutral on Abbott Laboratori...
Benzinga Newsdesk
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
Avi Kapoor
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
Avi Kapoor
Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
Piper Sandler Maintains Overweight on Abbott ...
Benzinga Newsdesk
Morgan Stanley Maintains Equal-Weight on Abbo...
Benzinga Newsdesk
Wednesday, October 16, 2024
Tech Stocks Stall, Small Caps Surge As Regional Banks Rally, Airlines Rocket: What's Driving Markets Wednesday?
Piero Cingari
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Price Over Earnings Overview: Abbott Laboratories
Benzinga Insights
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
Avi Kapoor
Abbott Executive Says Judge In Company's Tria...
Benzinga Newsdesk
Abbott Executive Says Volume-Based Procuremen...
Benzinga Newsdesk
Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast
Vandana Singh
Abbott Projects Q4 2024 Adjusted EPS Of $1.31...
Benzinga Newsdesk
Abbott Projects Full-Year 2024 Adjusted EPS O...
Benzinga Newsdesk
Abbott Laboratories Q3 2024 Adj. EPS $1.21 Be...
Benzinga Newsdesk
US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips
Shanthi Rexaline
Abbott Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Avi Kapoor
Nvidia, AMD, ASML And Other Chipmakers Drag Nasdaq Down: Fear Index Moves To 'Greed' Zone
Avi Kapoor
Morgan Stanley, Abbott Laboratories And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor
Tuesday, October 15, 2024
A Glimpse of Abbott Laboratories's Earnings Potential
Benzinga Insights
Monday, October 14, 2024
Beyond The Numbers: 9 Analysts Discuss Abbott Laboratories Stock
Benzinga Insights
Raymond James Maintains Outperform on Abbott ...
Benzinga Newsdesk
Columbus Day: Is Stock Market Open Today?
Benzinga Neuro
Thursday, October 10, 2024
Abbott Advances Pulsed Field Ablation Clinica...
Benzinga Newsdesk
Tuesday, October 08, 2024
RBC Capital Maintains Outperform on Abbott La...
Benzinga Newsdesk
Abbott Laboratories Analyst Is Bullish About MedTech, Non-MedTech Growth
Priya Nigam
A Look Into Abbott Laboratories Inc's Price Over Earnings
Benzinga Insights
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor
Oppenheimer Initiates Coverage On Abbott Labo...
Benzinga Newsdesk
Monday, October 07, 2024
How Is The Market Feeling About Abbott Laboratories?
Benzinga Insights
Thursday, October 03, 2024
WHO Approves First Mpox Diagnostic Test For E...
Benzinga Newsdesk
Tuesday, October 01, 2024
Evercore ISI Group Maintains Outperform on Ab...
Benzinga Newsdesk
Thursday, September 26, 2024
Navigating 6 Analyst Ratings For Abbott Laboratories
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch